APA (7th ed.) Citation

Chen, C., Chen, Z., Zhao, J., Wen, X., Yao, H., Weng, Z., . . . Wu, J. TMEM45A enhances palbociclib resistance and cellular glycolysis by activating AKT/mTOR signaling pathway in HR+ breast cancer. Nature Publishing Group.

Chicago Style (17th ed.) Citation

Chen, Cui, Zehong Chen, Jinze Zhao, Xinyun Wen, Hanming Yao, Zijin Weng, Huiping Xiong, Zongheng Zheng, and Juekun Wu. TMEM45A Enhances Palbociclib Resistance and Cellular Glycolysis by Activating AKT/mTOR Signaling Pathway in HR+ Breast Cancer. Nature Publishing Group.

MLA (9th ed.) Citation

Chen, Cui, et al. TMEM45A Enhances Palbociclib Resistance and Cellular Glycolysis by Activating AKT/mTOR Signaling Pathway in HR+ Breast Cancer. Nature Publishing Group.

Warning: These citations may not always be 100% accurate.